Triple drug maintenance therapy in renal transplantation.
Pallardó
L M
LM
Department of Nephrology, Hospital Universitario La Fe, Valencia, Spain.
Sánchez
J
J
Hernandez
M
M
Górriz
J L
JL
Sánchez
P
P
Beneyto
I
I
Rochera
A
A
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012189:Retrospective Studies
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine